5th Circ. Deals Biden A Loss in Medicare Drug Pricing Row

By Mark Payne · September 20, 2024, 6:11 PM EDT

A Fifth Circuit panel majority said that a healthcare trade association has standing to challenge the Biden administration's Medicare drug pricing program, allowing the group to sidestep agency administrative procedure and...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

Natl Infusion Center v. Becerra

Case Number

Court

Appellate - 5th Circuit

Nature of Suit

2440 Other Civil Rights

Date Filed

March 14, 2024

Recent Articles By Mark

December 17, 2024
Nurse Survey Rule Case Sheds Light On Loper At 2nd Circ.
December 10, 2024
9th Circ. Says Idaho Can't 'Veto' Federal Law In Abortion Row
December 10, 2024
Doctors Notch Free Speech Wins In 9th Circ. Abortion Cases
December 04, 2024
9th Circ. Keeps Block Of Idaho AG's Abortion Ban Stance
December 03, 2024
Experts Sound Alarm On RFK Jr.'s FDA Funding Ideas
December 02, 2024
9th Circ. Partially Upholds Block Of Idaho Abortion Travel Ban
November 26, 2024
In Court: Abortion, Gender Care, PBMs and Insulin Pricing
November 19, 2024
Doc Says Idaho Abortion Bans Sow 'Fear' In 2nd Week Of Trial
November 19, 2024
Congress' Dash For Telehealth Extensions: 4 Things To Know
November 19, 2024
Advocates Brace For Trump Shift On Emergency Abortion Law